Topical corticosteroids offer a more potent anti-inflammatory effect for the treatment of atopic dermatitis, but they may impair the restoration of the skin barrier and can induce skin atrophy, making topical calcineurin inhibitors more suitable for long-term treatment of the disease, according to a study published in the March issue of Allergy.
Topical corticosteroids impair restoration of skin barrier